Research and develop and resist the depression type natural medicine in Yunnan Have already entered clinical trial stage

Research and develop and resist the depression type natural medicine in Yunnan Have already entered clinical trial stage
A safe brand-new the intersection of function and mechanism resist depression new medicine expected to merchandize, news spreads on the 5th in the research institute of animal of Kunming of Chinese Academy of Sciences, should resist the intersection of depression and new the intersection of medicine and the intersection of and raw Saite Yue get national the intersection of food and pharmaceuticals administration a few days ago with the intersection of Chinese Academy of Sciences and the intersection of Kunming and the intersection of plant and natural the intersection of medicine and 1st that research institute declare jointly The medicine I that the office issues, II, III stage official written reply of the clinical trial.
Depression is a kind of common spiritual disease, because it causes disability leading, suicidal rate and disease are born and classified as one of the human ten major diseases, World Health Organization is expected by 2020, depression will be jumped to the second major disease in the world. The ill rate of Chinese depression is up to 3%- 5% at present, the patient invites 26 million of Damien. Kunming the intersection of plant and the intersection of research institute and researcher of discipline army group and Kunming Chen the intersection of animal and research institute the intersection of researcher and group Lin carry on, resist depression to be natural in the serial traditional Chinese medicine to depression slowly The screening of the active member, has found from a traditional Chinese medicine that has of little molecule compound that resists the depressed activity notably to grow Yue Saite, having finished, studied in front of born the clinic of Yue Saite and capsuling jointly, it is the first kind of new medicine of natural medicine in China new medicine is registered and classified.
It is reported, grows resisting depression mechanism and existing and resisting the depression medicine differently notably of Yue Saite, the good, poisonous side effect of security is not obvious, it is expected to become resisting new medicine of depression of brand-new function mechanism. Applied for China's patent and has already been authorized in 2007, would apply for PCT international monopoly in 2008, implement the registration of patent in 33 countries, Australia and Japan has already authorized. As the first kind of new medicine of country with independent intellectual property right, is studied before growing the clinic of Yue Saite and capsule, have obtained the scientific and technological key new products development plan of drawing room, country of Yunnan Province " Eleven five " Great new medicine formulates the great project of science and technology " Study before new medicine is clinical " , " the drug effect of resisting depression learns to appraise key technology " Subsidy of special, national natural science fund and State Intellectual Property Bureau. Raw Saite Yue and capsule study, get national the intersection of food and medicines, supervise the intersection of administration bureau and the intersection of medicines and evaluation centre and new the intersection of medicine and the intersection of evaluation conference and high approval of experts before being preparation clinical, have already obtained I, II, III stage official written reply of the clinical trial smoothly now.
Research and develop personnel to tell reporters, the clinical official written reply refers to obtaining the written instructions or comments that the clinical trial permitted, will do one after getting the clinical official written reply, two issues, three clinical trials, then could examine and approve and is listed, but different medicines, these three tests, demand not to be quite alike. Reach such new medicine list, need some time.
|